Novo Nordisk and Eli Lilly shares slid Wednesday on promising early-stage trial data from Roche’s latest obesity drug candidate.
Novo Nordisk and Eli Lilly shares slid Wednesday on promising early-stage trial data from Roche's latest obesity drug candidate.The results come as competition mounts in the fast-growing weight loss drug sector, with Roche's pill likely to provide an appealing alternative for patients who dislike injections.that a second drug candidate from its purchase of Carmot Therapeutics indicated positive results, further heating up competition in the weight loss drug market.
The results come as competition mounts in the fast-growing weight loss drug sector, with Roche's oral pill likely to provide an appealing alternative for patients who dislike injections.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from RocheNovo Nordisk and Eli Lilly shares slid Wednesday on promising early-stage trial data from Roche's latest obesity drug candidate.
Read more »
Novo Nordisk stock price falls after Eli Lilly weight loss drug outperforms OzempicPolitical News and Conservative Analysis About Congress, the President, and the Federal Government
Read more »
Intel, Nvidia, Eli Lilly rise premarket; BP, Novo Nordisk fallIntel, Nvidia, Eli Lilly rise premarket; BP, Novo Nordisk fall
Read more »
Microsoft and Eli Lilly are among the most overbought stocks as the first half endsThese are Wall Street's most overbought stocks.
Read more »
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug dataDrugmakers showed off data on weight loss and diabetes drugs. Also, Oracle announced the general availability of AI documentation assistant for doctors.
Read more »
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug dataDrugmakers showed off data on weight loss and diabetes drugs. Also, Oracle announced the general availability of AI documentation assistant for doctors.
Read more »